ArticleNature2023
FDA approves Alzheimer's drug lecanemab amid safety concerns.
Sara ReardonPubMed ↗Publisher ↗
No numbers read from the abstract.
83 papers cite itlatest 60 shown
this paperpooled ittrialcites it
ArticleNature2023
Sara ReardonPubMed ↗Publisher ↗
No numbers read from the abstract.